Alexander Hutchinson is a pharmacist who is specialized in Oncology in Phoenix, Arizona. Patients can reach him at 5777 E Mayo Blvd, Phoenix or contact him on 480-574-1172. Active license number of Alexander Hutchinson is S026462 for Oncology in Arizona. Alexander Hutchinson is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Alexander Hutchinson speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Alexander Hutchinson
Specialization:
Oncology
Credentials:
PHARMD
Gender:
Male
Location:
5777 E Mayo Blvd, Phoenix, Arizona, 85054-4502
Phone:
480-574-1172
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Alexander Hutchinson are as mentioned below.
NPI Number:
1053176016
NPI Enumeration Date:
19 Feb, 2024
NPI Last Update On:
19 Feb, 2024
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Alexander Hutchinson are as mentioned below.
Specialization
License Number
State
Status
Oncology
S026462
Arizona
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
5777 E Mayo Blvd, Attn: Inpatient Pharmacy Phoenix, Arizona
Zip:
85054-4502
Phone Number:
--
Fax Number:
--
Patients can reach Alexander Hutchinson at 5777 E Mayo Blvd, Phoenix, Arizona or can call on phone at 480-574-1172.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.